AMSTERDAM, Feb. 4, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, will host a conference call on Thursday, March 6, 2008 at 8:30 AM ET to report its fourth quarter 2007 and year-end financial results. The conference call will be hosted by Gearoid Faherty, Chief Executive Officer, and Mario Crovetto, Chief Financial Officer.
